Anlotinib is an oral small-molecule multi-targeted tyrosine kinase inhibitor, mainly indicated for the treatment of malignant tumors such as non-small cell lung cancer (NSCLC) and soft tissue sarcoma. Its price is affected by factors including specifications and regional medical insurance policies. Generally, the price of each box (7 capsules) ranges from150 to 600 USD. For the exact price, please refer to the actual selling price at hospitals or licensed pharmacies. The drug must be used strictly in accordance with medical advice, and shall not be purchased or dosed without authorization.
Factors Affecting the Price
Specification Differences
Common specifications include 8 mg, 10 mg, and 12 mg. Prices vary by specification, with higher doses typically commanding higher prices.
Medical Insurance Policies
Anlotinib has been included in the National Medical Insurance Catalog (2023 Edition). The medical insurance reimbursement rate varies by regional policies. In some areas, the out-of-pocket cost per box can be reduced to 1,000–2,000 yuan after reimbursement.
Purchase Channels
Prices may differ between hospital pharmacies and retail pharmacies. It is recommended to purchase the drug through formal medical institutions.
Medication Precautions
Prescription Drug Management
Anlotinib is a prescription drug and can only be purchased with a prescription issued by an oncologist or specialist in related fields. It shall not be used without authorization.
Treatment Cycle
A typical treatment cycle consists of 2 weeks of administration followed by 1 week of withdrawal. The specific regimen shall be determined by the physician based on the patient’s condition.
Side Effect Monitoring
Common adverse reactions include hypertension, hand-foot skin reaction, and proteinuria. Regular monitoring of blood pressure, routine urine tests, as well as liver and kidney function is required.
Suggestions for Cost Savings
Medical Insurance Registration
Complete the special outpatient disease registration as early as possible after diagnosis to increase the reimbursement rate.
Charitable Assistance
Some pharmaceutical companies or public welfare organizations offer patient assistance programs. Eligible patients can apply for drug cost reduction or exemption.
Treatment Regimen Optimization
Maintain full communication with the attending physician to adjust the medication based on efficacy and tolerance, avoiding unnecessary economic burden.
Medical Guidance
Prior to the administration of anlotinib, complementary examinations such as pathological diagnosis and gene testing are required to confirm compliance with the indications. During treatment, it is recommended to conduct imaging assessments (e.g., CT scans) every 2–3 months to evaluate the therapeutic effect, and attend follow-up visits on schedule. In case of severe adverse reactions (e.g., grade Ⅲ or above hypertension or bleeding tendency), the drug must be discontinued immediately and medical attention should be sought.
